ORTEXORTEX News
Tracking XLU? Get live short interest, options flow, and signals on ORTEX.Sign up free →
XL
Trader NoteXLU

XLU Options Normalisation Complete as Short Interest Stabilises

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 21 Oct 2026, 19:18

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

XLU, the utilities sector ETF, has now fully retraced the extreme defensive positioning that defined September, with the put/call ratio back to neutral even as short interest holds near its recent elevated range.

The options story is the clearest signal this week. The PCR has settled at 1.56, almost exactly in line with its 20-day average of 1.54, giving a z-score of just 0.05. That is a dramatic reversal from the late-September peak, when the ratio was running above 2.6 and puts outnumbered calls by more than two-and-a-half to one. The note published on October 14 flagged the normalisation in progress, with the PCR at 1.38 and still below its then-average. Since then, the 20-day mean itself has compressed as those extreme September readings roll out of the window. Options positioning is no longer defensive by any meaningful measure; it has returned to background noise.

Short interest, by contrast, has barely moved. At 12.9% of free float, it remains elevated for a broad sector ETF, though the week-on-week reading is essentially flat, down just under 1%. The monthly trend shows a modest 1.1% increase, consistent with the gentle drift higher flagged last week. There is no urgency in the lending market: borrow costs are running at 0.42%, down sharply over the past month as the cost eased from the 0.66% peak seen in late September. Availability is comfortable at 563%, meaning there are more than five shares available to borrow for every one currently lent out. The 52-week minimum availability was 5.4%, so conditions today are loose by any historical comparison for this name.

The price has caught up with the improved sentiment. XLU closed at $41.88 on October 20, up 1.3% on the day and roughly flat on the week. The one-month gain is 1.9%. The ORTEX short score sits at 43.2, down from 50.1 on October 7 and broadly consistent with the easing in both options defensiveness and borrow cost. The combined score of 43.1 puts XLU in the lower half of the short-pressure universe, suggesting the market views the current short position as a structural hedge rather than a high-conviction bearish trade.

Institutional data from June 30 shows broad distribution across broker-dealer and wealth management channels, with Morgan Stanley and JPMorgan each holding just over 4% of shares. Both trimmed positions in the period, as did several other large holders, though Bank of America, Goldman Sachs and BNP Paribas each added meaningfully. The pattern looks less like a coordinated exit and more like routine rebalancing across a widely held defensive ETF.

The one anomaly in the earnings history is the December 2025 reading, which shows a one-day move of minus 51%, almost certainly a data artefact rather than a genuine price event for this ETF. The surrounding prints are unremarkable: plus 1.5% in June 2026 and plus 0.6% in June 2025. The analyst data carries a timestamp from 2008 and is not usable.

With the options-to-short-interest divergence that drove the last two notes now largely resolved, what to watch next is whether the steady short position at 12.9% of float begins to move in either direction as rate expectations shift into year-end.

Stocks in this article

See the live data behind this article on ORTEX.

Open XLU on ORTEX →

How this article was generated

Generated
21 Oct 2026, 19:25
Data as of
21 Oct 2026, 19:18
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.